| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
109,281 |
108,241 |
$17.88M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
32,983 |
32,676 |
$7.82M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
19,136 |
18,991 |
$6.14M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
19,623 |
19,323 |
$2.50M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
11,679 |
11,558 |
$1.03M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,429 |
7,126 |
$437K |
| 36415 |
Collection of venous blood by venipuncture |
35,675 |
33,146 |
$390K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,090 |
5,072 |
$381K |
| 71045 |
Radiologic examination, chest; single view |
17,918 |
17,741 |
$251K |
| T1016 |
Case management, each 15 minutes |
5,106 |
1,334 |
$205K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,001 |
502 |
$182K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,518 |
4,199 |
$176K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,303 |
3,236 |
$122K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
591 |
365 |
$115K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
16,261 |
16,077 |
$93K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,847 |
10,484 |
$80K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,603 |
9,032 |
$71K |
| 81025 |
|
9,419 |
9,377 |
$69K |
| 95811 |
|
220 |
220 |
$66K |
| 80053 |
Comprehensive metabolic panel |
6,893 |
6,208 |
$62K |
| 85027 |
|
10,771 |
10,666 |
$62K |
| 81001 |
|
14,570 |
13,828 |
$60K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
13 |
13 |
$40K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
718 |
715 |
$34K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
244 |
244 |
$33K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,254 |
3,774 |
$31K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
223 |
223 |
$30K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
525 |
490 |
$28K |
| 81003 |
|
13,409 |
13,341 |
$28K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
135 |
134 |
$23K |
| 87400 |
|
819 |
819 |
$20K |
| D9999 |
Unspecified adjunctive procedure, by report |
12 |
12 |
$12K |
| 84484 |
|
957 |
800 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
858 |
853 |
$11K |
| 94060 |
|
423 |
423 |
$10K |
| 70450 |
Computed tomography, head or brain; without contrast material |
209 |
208 |
$10K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
52 |
52 |
$10K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,392 |
1,267 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,316 |
1,268 |
$9K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
94 |
94 |
$8K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
61 |
25 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
639 |
599 |
$7K |
| 83690 |
|
1,135 |
1,109 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,406 |
1,171 |
$6K |
| 80143 |
|
300 |
296 |
$5K |
| 80179 |
|
298 |
295 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
147 |
147 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
147 |
147 |
$4K |
| 94729 |
|
103 |
103 |
$4K |
| 94726 |
|
86 |
86 |
$3K |
| 71250 |
|
63 |
63 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
28 |
28 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
28 |
28 |
$2K |
| 76801 |
|
26 |
26 |
$2K |
| 84703 |
|
186 |
186 |
$1K |
| 94150 |
|
57 |
55 |
$1K |
| 73130 |
|
40 |
40 |
$735.85 |
| 73610 |
|
40 |
40 |
$701.35 |
| 87430 |
|
39 |
39 |
$564.10 |
| 83615 |
|
75 |
71 |
$403.00 |
| 93017 |
|
13 |
13 |
$351.44 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
130 |
53 |
$341.84 |
| 82330 |
|
25 |
25 |
$319.83 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,844 |
2,833 |
$299.02 |
| 73110 |
|
13 |
13 |
$246.72 |
| 87070 |
|
24 |
24 |
$180.08 |
| 82728 |
|
14 |
14 |
$169.68 |
| 80051 |
|
14 |
14 |
$164.92 |
| 81002 |
|
53 |
52 |
$161.90 |
| 83550 |
|
15 |
15 |
$116.55 |
| 84156 |
|
33 |
24 |
$107.93 |
| 87210 |
|
26 |
26 |
$106.68 |
| 83540 |
|
15 |
15 |
$86.25 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
63 |
63 |
$65.80 |
| 82565 |
|
13 |
13 |
$63.48 |
| 82570 |
|
14 |
12 |
$59.93 |
| 85014 |
|
26 |
26 |
$58.91 |
| 84520 |
|
13 |
13 |
$48.98 |
| 82947 |
|
13 |
13 |
$48.74 |
| A4351 |
Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each |
16 |
16 |
$35.91 |
| A4364 |
Adhesive, liquid or equal, any type, per oz |
12 |
12 |
$32.40 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
25 |
25 |
$9.96 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
158 |
156 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
404 |
201 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
527 |
507 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
12 |
12 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
13 |
12 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,084 |
1,061 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
71 |
41 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
45 |
41 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
12 |
12 |
$0.00 |